Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortInjectable disease-modifying therapy for relapsing multiple sclerosis.Injection for relapsing MS with no flu-like effects.
Body systemBrain & NervesBrain & Nerves
Drug classMultiple sclerosis therapiesMultiple sclerosis therapies
SupplyPrescription onlyPrescription only
Main usesRelapsing MS, Clinically isolated syndromeRelapsing MS, Clinically isolated syndrome
How it worksCalms the immune attacks on nerve coverings.Diverts the immune system away from attacking nerve coverings.
Starts workingMonths for benefitMonths for benefit
Half-lifeHours (effect lasts longer)Not applicable
Typical adult doseDepends on the product: 30 micrograms IM weekly, 22–44 micrograms SC three times a week, or 250 micrograms SC every other day.20 mg daily or 40 mg three times a week by subcutaneous injection.
FormsSubcutaneous injection, Intramuscular injectionSubcutaneous injection
Common side effectsFlu-like symptoms, Injection site reactions, Headache, Muscle achesInjection site reactions, Flushing, Chest tightness after injection, Anxiety
Serious side effectsLiver injury, Depression, Low blood counts, Thyroid problemsLipoatrophy at injection sites, Immediate post-injection reaction, Liver injury (rare)
Don't take ifSevere depression; Uncontrolled epilepsy; Decompensated liver diseaseAllergy to glatiramer or mannitol
AlcoholBest to limit. Alcohol adds liver stress.Usually no problem in moderation. No known interaction.
PregnancyUse with cautionStop before planned pregnancy or review risk with specialist.Use with cautionConsidered relatively safe; discuss with your specialist.
BreastfeedingGenerally considered safeLarge molecule; minimal transfer into milk.Generally considered safeNot absorbed orally by the baby.
In use since——
Brand namesUnited States: Avonex, Rebif, BetaseronUnited Kingdom: Avonex, Rebif, BetaferonIndia: Avonex, Rebif, BetaferonUnited States: Copaxone, GlatopaUnited Kingdom: Copaxone, BrabioIndia: Copaxone
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL03AB07L03AX13

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker